US Senator Sanders favors Trump plan to take stake in Intel, others

Senator Bernie Sanders has endorsed President Trump's initiative to convert U.S. government grants to semiconductor manufacturers, including a $10.9 billion award to Intel, into equity stakes in these companies. This unusual bipartisan alignment on state intervention in private enterprise, driven by the Commerce Secretary's push for a "return on investment" for taxpayer-funded subsidies from the 2022 Chips and Science Act, signals a broader shift in the Trump administration's economic policy, mirroring recent moves in AI, rare earths, and steel. Sanders emphasized the need for taxpayers to receive a "reasonable return" on these significant federal investments, particularly as much of the Chips Act funding remains undisbursed.

Analysis

A significant policy shift is underway as the Trump administration, with unexpected bipartisan support from Senator Bernie Sanders, plans to convert government grants under the 2022 Chips and Science Act into equity stakes. This directly impacts companies like Intel, which was slated to receive a $10.9 billion grant, and introduces new risk for other recipients such as Micron and TSMC whose funding has not yet been disbursed. The rationale, articulated by both Sanders and the administration, is to ensure taxpayers receive a "reasonable return on investment" for the subsidies. The moderately negative market sentiment, particularly for Intel (sentiment score -0.4), reflects investor concerns over potential shareholder dilution and increased government influence. This move is not an isolated incident but part of a broader trend of state intervention, evidenced by the government taking a 15% revenue share from Nvidia and AMD's AI chip sales to China and securing a "golden share" in the Nippon Steel-U.S. Steel deal. The strong political alignment on this issue suggests a durable change in how the U.S. government engages with strategically vital private sector industries.

Key Decisions for Investors

• Investors in CHIPS Act beneficiaries like Intel, Micron, and TSMC should immediately reassess their valuation models to account for the material risk of shareholder dilution and the potential for reduced strategic flexibility due to government equity stakes.
• The bipartisan support for this policy indicates a sustained increase in political and regulatory risk for the U.S. semiconductor sector, necessitating a higher risk premium for long-term investments in the industry.
• Monitor upcoming announcements from the Commerce Department regarding the specific terms of these equity conversions, as the structure (e.g., warrants, common stock) will be critical in determining the precise financial impact and level of government control.